180 Life Sciences Stock Gains 8%

Shares of 180 Life Sciences Corp. (ATNF) are gaining over 8% on Wednesday morning.

ATNF is currently trading at $3.4300, up $0.2600 or 8.2019%, on the Nasdaq. The stock opened its trading at $3.6700 after closing previous day's trading at $3.1700. The stock has traded between $1.1800 and $71.4000 in the past 52-week period.

In the publication, Professor Jagdeep Nanchahal, chairman of the medical advisory board of 180 Life Sciences, and his colleague at the University of Oxford, describe the limitations for the current treatments for late-stage Dupuytren's disease and the lack of evidence based on randomized double blind, placebo-controlled trials for treatments for early-stage disease, such as intranodular injection of steroid or radiotherapy.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT